Mucoactive drugs for asthma and COPD: any place in therapy?

Abstract excerpt

Airway mucus hypersecretion is a clinical and pathophysiological feature of a number of severe respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). The importance of mucus hypersecretion to the morbidity and mortality of asthma is acknowledged, whereas in COPD it appears to affect only certain groups of patients, particularly the elderly and those prone to chest infections....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Asthma
• Share to Clinical Trials as Topic
• Share to Deoxyribonuclease I